Current Assets
Inventories
Amgen Inventories decreased by 0.6% to $6.19B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 8.1%, from $6.73B to $6.19B. Over 5 years (FY 2020 to FY 2025), Inventories shows an upward trend with a 9.8% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryEfficiency
SignalContext dependent
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026Apr 30, 2026
How to read this metric
Rising inventory levels may indicate anticipated demand growth or, conversely, potential obsolescence and overproduction risks.
Detailed definition
The total value of raw materials, work-in-progress, and finished goods held by the company for sale in the ordinary cour...
Peer comparison
Biotech peers maintain inventory levels based on clinical trial success and regulatory approval timelines.
Metric ID:
inventoriesHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.12B | $4.15B | $4.09B | $4.41B | $4.55B | $4.76B | $4.93B | $5.01B | $4.98B | $5.03B | $9.52B | $8.72B | $8B | $7.36B | $7B | $6.73B | $6.58B | $6.35B | $6.23B | $6.19B |
| QoQ Change | — | +0.9% | -1.6% | +8.0% | +3.2% | +4.5% | +3.6% | +1.6% | -0.7% | +1.0% | +89.4% | -8.3% | -8.4% | -7.9% | -4.9% | -3.8% | -2.2% | -3.6% | -1.9% | -0.6% |
| YoY Change | — | — | — | — | +10.7% | +14.6% | +20.7% | +13.6% | +9.3% | +5.7% | +93.1% | +74.1% | +60.6% | +46.5% | -26.5% | -22.9% | -17.7% | -13.8% | -11.0% | -8.1% |
Range$4.09B – $9.52B
CAGR+9.0%
Avg YoY Growth+15.5%
Median YoY Growth+10.0%
Current Streak9 quarters decline
Inventories at Other Companies
Frequently Asked Questions
- What is Amgen's inventories?
- Amgen (AMGN) reported inventories of $6.19B in Q1 2026.
- How has Amgen's inventories changed year-over-year?
- Amgen's inventories decreased by 8.1% year-over-year, from $6.73B to $6.19B.
- What is the long-term trend for Amgen's inventories?
- Over 5 years (2020 to 2025), Amgen's inventories has grown at a 9.8% compound annual growth rate (CAGR), from $3.89B to $6.23B.
- What does inventories mean?
- The value of all products and materials the company currently has in stock.